Skip to main content

ODYSSEY: Alirocumab improves lipids but not glycemic targets in 2DM

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
ODYSSEY: Alirocumab improves lipids but not glycemic targets in 2DM

User login

Username

Password

Reset your password

Type	Lead	score